AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.

Sigrid NakkenØystein EikremHans-Peter MartiChristian BeislandLeif BostadAndreas SchererArnar FlatbergVidar BeisvagEleni SkandalouJessica FurriolPhilipp Strauss

Published in: Cancer cell international (2021)

AGAP2-AS1 may represent a novel biomarker identifying high-risk ccRCC patients currently classified as "low risk" at the time of surgery.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
minimally invasive
chronic kidney disease
prognostic factors
coronary artery disease
surgical site infection